High Efficacy and Safety of the combination HCV Regimen Grazoprevir and Elbasvir for 8 Weeks in Treatment-Naive, non-severe fibrosis HCV GT1b-Infected Patients: Interim Results of the STREAGER study.

Affiliation auteurs!!!! Error affiliation !!!!
TitreHigh Efficacy and Safety of the combination HCV Regimen Grazoprevir and Elbasvir for 8 Weeks in Treatment-Naive, non-severe fibrosis HCV GT1b-Infected Patients: Interim Results of the STREAGER study.
Type de publicationJournal Article
Year of Publication2017
AuteursAbergel A, Loustaud-Ratti V, Di Martino V, Gournay J, Larrey DG, Fouchard-Hubert I, Chanteranne B, Dodel M, Faure F, Pereira B, Lamblin G, Campos C, Muti L, Reymond M, Teilhet C
JournalHEPATOLOGY
Volume66
Pagination1257A-1258A
Date PublishedDEC
Type of ArticleMeeting Abstract
ISSN0270-9139